Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
09/07/1992 | WO1992015683A1 Humanized and chimeric monoclonal antibodies |
09/07/1992 | WO1992015681A1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN |
09/07/1992 | CA2105572A1 Human galanin, cdna clones encoding human galanin and a method of producing human galanin |
09/07/1992 | CA2062211A1 Substituted 1(2h)-isoquinolinones |
09/07/1992 | CA2062132A1 Substituted fused pyrimidinones |
09/05/1992 | WO1992015332A1 Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
09/05/1992 | CA2104684A1 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
09/03/1992 | WO1992014750A1 Recombinant thrombin receptor and related pharmaceuticals |
09/03/1992 | WO1992014749A1 Thyroid-derived chondrocyte-stimulating factor |
09/03/1992 | WO1992014727A1 3-piperidinylmethylcarboxylate substituted indoles |
09/03/1992 | WO1992014484A1 Methods and compositions for the treatment of infection and control of flora |
09/03/1992 | WO1992014467A1 Therapeutic agents for the treatment of multidrug resistance to cancers |
09/03/1992 | WO1992014462A1 Cytokine inhibitors |
09/03/1992 | WO1992014456A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
09/03/1992 | DE4106570A1 Neue inhibitoren der endothelzell-proliferation New inhibitors of endothelial cell proliferation- |
09/03/1992 | CA2105179A1 3-piperidinylmethylcarboxylate substituted indoles |
09/03/1992 | CA2104394A1 Recombinant thrombin receptor and related pharmaceuticals |
09/02/1992 | WO1992015585A1 1-azabicyclo[3.2.2]nonan-3-amine derivatives |
09/02/1992 | EP0501892A1 Diazotized heterocyclic derivatives N-substituted by a biphenylmethyl group, their preparation and pharmaceutical compositions containing them |
09/02/1992 | EP0501870A1 New pharmaceutical compositions, particularly for the treatment of functional infections of the large intestines, and process for obtaining them |
09/02/1992 | EP0501678A2 Treatment of ocular hypertension with a synergistic combination |
09/02/1992 | EP0501656A2 New benzene derivatives having (NGF) production-promoting activity |
09/02/1992 | EP0501641A1 L-2-oxothiazolidine-4-carboxylate and glutathion esters for the treatment of hepatic diseases |
09/02/1992 | EP0501578A1 Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis |
09/02/1992 | EP0501568A1 Substituted cyclic sulphamide derivatives |
09/02/1992 | EP0501378A1 NMDA Antagonists |
09/02/1992 | EP0501322A1 3-Piperidinylmethylcarboxylate substituted indoles |
09/02/1992 | EP0501269A1 Imidazole and benzimidazole derivatives |
09/02/1992 | EP0501251A2 The enantiomer (+)-N-(2-ethoxyphenyl)-N',N'-(1,2,2-trimethylpropyl)-2-nitroethen-1,1-diamine, method for its preparation and its use |
09/02/1992 | EP0500989A1 N-(alpha-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents |
09/02/1992 | EP0500785A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
09/02/1992 | EP0500745A1 Metal-peptide compositions and cosmetic methods for stimulating hair growth |
09/02/1992 | EP0500653A1 Inhibitors of purine nucleoside phosphorylase |
09/02/1992 | EP0500621A1 Cycloalkyl-substituted glutaramide diuretic agents |
09/02/1992 | EP0494974A4 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
09/02/1992 | EP0401243B1 Medicinal preparations characterized by a combination of cytostatic agents, hormonal therapeutic agents and phosphone derivatives |
09/01/1992 | US5143926 Substituted pyridine-2,4-dicarboxylic acid compounds and methods of use thereof |
09/01/1992 | US5143920 Substituted 4-aminoquinoline derivatives as gastric secretion inhibitors |
09/01/1992 | US5143829 One of the alanine residues following N-terminal methionine is removed |
09/01/1992 | CA1307003C Phenyl carbamate |
08/29/1992 | WO1992015563A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof |
08/29/1992 | CA2104879A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof |
08/28/1992 | WO1992015608A1 N-(α-SUBSTITUTED-PYRIDINYL)CARBONYL DIPEPTIDE ANTIHYPERTENSIVE AGENTS |
08/28/1992 | CA2081471A1 N-(ó-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents |
08/28/1992 | CA2061812A1 Substituted cyclic sulphamide derivatives |
08/27/1992 | WO1992014474A1 Methods for the treatment of osteoporosis |
08/27/1992 | CA2061271A1 Method for the treatment of hepatic failure and disease |
08/27/1992 | CA2061159A1 Imidazole and benzimidazole derivatives |
08/26/1992 | WO1992014364A1 Opiate receptor antagonist modulates hyperkinetic movement disorder |
08/26/1992 | EP0500426A1 2,6-Dimethyl-4-(4'-hydroxy-3',5'-di-t-butylphenyl)-1,4-dihydropyridine derivatives, process for their preparation and their use as free radical scavengers |
08/26/1992 | EP0500409A1 4-Pyrimidinone derivatives, their preparation and their application in therapy |
08/26/1992 | EP0500387A2 Methods and compositions for the treatment of infection and control of flora using haloperoxidase |
08/26/1992 | EP0500297A1 Substituted pyridinones and pyrimidinones as angiotensin II antagonists |
08/26/1992 | EP0500136A1 1,2,4-Triazolo[1,5-a]pyrimidine derivatives, a process for preparing them as well as medicaments containing them and the use of them |
08/26/1992 | EP0499995A2 Piperidine derivatives |
08/26/1992 | EP0499831A2 Combination of active agents comprising a sydnonimin derivate and a hirudin |
08/26/1992 | EP0499679A1 Therapeutic agent for diabetic gangrene |
08/26/1992 | EP0499662A1 Compositions with enhanced penetration |
08/26/1992 | EP0499625A1 Conglutinin fragments, their production and use |
08/26/1992 | EP0483219A4 Enhancement of musculature in animals |
08/26/1992 | CN1063870A Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes |
08/26/1992 | CN1063869A Nitrogenous bicyclic derivatives, their preparation process, intermediates obtained, their use as medicaments and pharomaceutical composition containing them |
08/25/1992 | US5142048 Enzyme inhibitor; carbamoyl group-containing acids |
08/25/1992 | US5141957 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
08/25/1992 | US5141952 Heterocyclic dicarboxylic acids |
08/25/1992 | US5141950 Benzimidazole compounds and their use |
08/25/1992 | US5141945 5-Hydroxytryptamine antagonists, treatment or prevention of nausea and vomiting |
08/25/1992 | US5141943 Water soluble uridine phosphorylase inhibitors, reducing toxicity and anemia of antiviral drugs |
08/25/1992 | CA1306746C Cyclic amino-thioacetal amides, a process for the preparation thereofand pharmaceutical compositions containing them |
08/25/1992 | CA1306744C Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
08/23/1992 | WO1992014480A1 Use of gm-csf and g-csf to promote accelerated wound healing |
08/23/1992 | CA2081104A1 Use of gm-csf and g-csf to promote accelerated wound healing |
08/23/1992 | CA2061629A1 5-(substituted amino)-1,2,4- triazolo¬1,5-a|pyrimidine derivatives |
08/23/1992 | CA2061538A1 2-substituted quinolines, processes for their preparation and their use in medicaments |
08/22/1992 | CA2061557A1 New benzene derivatives having ngf production-promoting activity |
08/21/1992 | WO1992014716A1 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
08/21/1992 | CA2101542A1 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
08/21/1992 | CA2061488A1 Combination of active substances comprising a sydnone imine and a hirudin |
08/21/1992 | CA2061456A1 4-pyrimidinone derivatives, their preparation and their application in therapy |
08/21/1992 | CA2060965A1 Piperidine derivatives |
08/20/1992 | WO1992013870A1 Human platelet-derived growth factor receptors |
08/20/1992 | WO1992013864A1 Acylamino-alkyliden-hydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases |
08/20/1992 | WO1992013855A1 (2-imidazolin-2-ylamino) tetrahydroquinolaxines and methods for using same |
08/20/1992 | WO1992013844A1 Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
08/20/1992 | WO1992013565A1 Growth factor containing matrix for the treatment of cartilage lesions |
08/20/1992 | WO1992013561A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
08/20/1992 | WO1992013553A2 Method and agents for promoting wound healing |
08/20/1992 | WO1992013536A1 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
08/20/1992 | CA2365269A1 Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
08/20/1992 | CA2103676A1 Method and agents for promoting wound healing |
08/20/1992 | CA2101632A1 Human platelet-derived growth factor receptors |
08/19/1992 | EP0499444A1 N-imidazolyl derivatives of substituted alkoxyimino tetrahydronaphthalenes and chromans |
08/19/1992 | EP0499415A1 Pyridine and quinoline derivatives, processes for their manufacture and their use as angiotensin II antagonists |
08/19/1992 | EP0499414A2 Pyridine derivatives as angiotensin II antagonists, processes for their preparation and pharmaceutical compositions containing them |
08/19/1992 | EP0499164A1 Injectable compositions to replace lubricating body fluids |
08/19/1992 | EP0499162A2 GM-CSF inhibiting oligopeptides |
08/19/1992 | EP0499142A2 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs |
08/19/1992 | EP0498856A1 Inhibitor of laminin neurite promoting activity |
08/19/1992 | CN1063690A Tabersonine derivatives pharmaceutical composition containing same and process for preparing same |
08/19/1992 | CN1063685A Calcium uptake inhibitors |